- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 153.15M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $30.03K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $64.19K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $3.09M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $2.82M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.09M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.83M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $44.07K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $80.69K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.48M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.56M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 149.84M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$633.08K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $152.85K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $425.95K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $432.04K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $197.17K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$857.37K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $30.16K |